Abstract:The discovery of induced pluripotent stem cells (iPSCs) allows for establishment of human embryonic stem-like cells from various adult human somatic cells (e.g., fibroblasts), without the need for destruction of human embryos. This provides an unprecedented opportunity where patient-specific iPSCs can be subsequently differentiated to many cell types, e.g., cardiac cells and neurons, so that we can use these iPSC-derived cells to study patient-specific disease mechanisms and conduct drug testing and screening. Critically, these cells have unlimited therapeutic potentials, and there are many ongoing clinical trials to investigate the regenerative potentials of these iPSC-derivatives in humans. However, the traditional iPSC reprogramming methods have problem of insertional mutagenesis because of use of the integrating viral vectors. While a number of advances have been made to mitigate this issue, including the use of chemicals, excisable and non-integrating vectors, and use of the modified mRNA, safety remains a concern. Both integrating and non-integrating methods also suffer from many other limitations including low efficiency, variability, and tumorigenicity. The non-integrating mRNA reprogramming is of high efficiency, but it is sensitive to reagents and need approaches to reduce the immunogenic reaction. An alternative non-integrating and safer way of generating iPSCs is via direct delivery of recombinant cell-penetrating reprogramming proteins into the cells to be reprogrammed, but reprogramming efficiency of the protein-based approach is extremely low compared to the conventional virus-based nuclear reprogramming. Herein, we describe detailed steps for efficient generation of human iPSCs by protein-based reprogramming in combination with stimulation of the Toll-like receptor 3 (TLR3) innate immune pathway.

Generation of Ips Cells Using Defined Factors Linked Via the Self-Cleaving 2A Sequences in a Single Open Reading Frame

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells

Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells

Generation of induced pluripotent stem cells using site-specific integration with phage integrase

Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells

Integration-free Methods for Generating Induced Pluripotent Stem Cells.

Simple derivation of transgene-free iPS cells by a dual recombinase approach

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts

Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors

Measles vector as a multigene delivery platform facilitating iPSC reprogramming

Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling

Enhanced Generation of Integration-free Ipscs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.

Generation of Transgene-free Induced Pluripotent Stem Cells with Non-viral Methods

Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

Efficient generation human induced pluripotent stem cells from human somatic cells with Sendai-virus

Gene-delivery Systems for Ips Cell Generation